A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)
日本开展的S-1和顺铂联合胸部放疗，随后进行度伐利尤单抗治疗不可切除的局部晚期非小细胞肺癌的II期研究（SAMURAI研究）
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835921998588
Tanzawa, Shigeru; Ushijima, Sunao; Shibata, Kazuhiko; Shibayama, Takuo; Bessho, Akihiro; Kaira, Kyoichi; Misumi, Toshihiro; Shiraishi, Kenshiro; Matsutani, Noriyuki; Tanaka, Hisashi; Inaba, Megumi; Haruyama, Terunobu; Nakamura, Junya; Kishikawa, Takayuki; Nakashima, Masanao; Iwasa, Keiichi; Fujiwara, Keiichi; Kohyama, Tadashi; Kuyama, Shoichi; Miyazawa, Naoki; Nakamura, Tomomi; Miyawaki, Hiroshi; Ishida, Hiroo; Oda, Naohiro; Ishikawa, Nobuhisa; Morinaga, Ryotaro; Kusaka, Kei; Fujimoto, Nobukazu; Yokoyama, Toshihide; Gemba, Kenichi; Tsuda, Takeshi; Nakagawa, Hideyuki; Ono, Hirotaka; Shimizu, Tetsuo; Nakamura, Morio; Kusumoto, Sojiro; Hayashi, Ryuji; Shirasaki, Hiroki; Ochi, Nobuaki; Aoe, Keisuke; Kanaji, Nobuhiro; Kashiwabara, Kosuke; Inoue, Hiroshi; Seki, Nobuhiko
